Discovery and in vitro evaluation of potent kinase inhibitors:: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines

被引：31

作者：

Alberti, MJ ^{[1
]}

Auten, EP ^{[1
]}

Lackey, KE ^{[1
]}

McDonald, OB ^{[1
]}

Wood, ER ^{[1
]}

Preugschat, F ^{[1
]}

Cutler, GJ ^{[1
]}

Kane-Carson, L ^{[1
]}

Liu, W ^{[1
]}

Jung, DK ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 16期

关键词：

kinase inhibitor; VEGFR; GSK; Erb; EGFR;

D O I：

10.1016/j.bmcl.2005.05.100

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The discovery, synthesis, potential binding mode, and in vitro kinase profile of several pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines as potent kinase inhibitors are discussed. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：3778 / 3781

页数：4

共 12 条

[1] Solution-phase synthesis of a library of 3,5,7-trisubstituted 3H-[1,2,3]triazolo[4,5-d]pyrimidines
Baindur, N
Chadha, N
Player, MR
[J]. JOURNAL OF COMBINATORIAL CHEMISTRY, 2003, 5 (05): : 653 - 659
[2] Oncogenic kinase signalling
Blume-Jensen, P
Hunter, T
[J]. NATURE, 2001, 411 (6835) : 355 - 365
[3] Recent kinase and kinase inhibitor X-ray structures: Mechanisms of inhibition and selectivity insights
Cherry, M
Williams, DH
[J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (06) : 663 - 673
[4] Cockerill S. G., 2002, CURR TOP MED CHEM, V2, P1001
[5] Protein kinases - the major drug targets of the twenty-first century?
Cohen, P
[J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) : 309 - 315
[6] Graveleau N, 2003, SYNTHESIS-STUTTGART, P1739
[7] Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy
Gschwind, A
Fischer, OM
Ullrich, A
[J]. NATURE REVIEWS CANCER, 2004, 4 (05) : 361 - 370
[8] Signaling networks: The origins of cellular multitasking
Jordan, JD
Landau, EM
Iyengar, R
[J]. CELL, 2000, 103 (02) : 193 - 200
[9] Saporito MS, 2002, PROGR MED CHEM, V40, P23, DOI 10.1016/S0079-6468(08)70081-X
[10] Tyrosine kinase inhibitors.: 16.: 6,5,6-tricyclic benzothieno[3,2-d]pyrimidines and pyrimido[5,4-b]- and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase
Showalter, HDH
Bridges, AJ
Zhou, HR
Sercel, AD
McMichael, A
Fry, DW
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) : 5464 - 5474

← 1 2 →